Insider Transactions in Q4 2021 at Olema Pharmaceuticals, Inc. (OLMA)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
10,000
-1.69%
|
$100,000
$10.3 P/Share
|
|
Dec 10
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,251
-68.12%
|
$52,510
$10.39 P/Share
|
|
Dec 10
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+40.52%
|
$10,502
$2.06 P/Share
|
|
Nov 30
2021
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
739,675
+8.81%
|
$6,657,075
$9.39 P/Share
|
|
Nov 29
2021
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
400
-0.04%
|
$9,600
$24.76 P/Share
|
|
Nov 10
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
27,668
-93.92%
|
$719,368
$26.88 P/Share
|
|
Nov 10
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,668
+42.97%
|
$276,680
$10.53 P/Share
|
|
Oct 19
2021
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
12,000
-0.57%
|
$336,000
$28.03 P/Share
|
|
Oct 14
2021
|
Sean Bohen PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,000
-4.37%
|
$150,000
$30.8 P/Share
|
|
Oct 14
2021
|
Sean Bohen PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.0%
|
$20,000
$4.82 P/Share
|
|
Oct 11
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,251
-46.82%
|
$141,777
$27.83 P/Share
|
|
Oct 11
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+42.72%
|
$10,502
$2.06 P/Share
|